Hans Slabbynck

1.2k total citations
30 papers, 735 citations indexed

About

Hans Slabbynck is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Hans Slabbynck has authored 30 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 8 papers in Epidemiology and 8 papers in Physiology. Recurrent topics in Hans Slabbynck's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Pneumonia and Respiratory Infections (5 papers) and Respiratory and Cough-Related Research (5 papers). Hans Slabbynck is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Pneumonia and Respiratory Infections (5 papers) and Respiratory and Cough-Related Research (5 papers). Hans Slabbynck collaborates with scholars based in Belgium, Luxembourg and Switzerland. Hans Slabbynck's co-authors include Patrick Alexander, Marc Noppen, Peter Driesen, Ingel Demedts, Geert M. Verleden, Guy Brusselle, Jerina Boelens, Bénédicte Demeyere, R DEMAN and Paul Jordens and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and European Respiratory Journal.

In The Last Decade

Hans Slabbynck

28 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Slabbynck Belgium 10 592 359 200 72 71 30 735
Ajmal Khan India 11 412 0.7× 240 0.7× 124 0.6× 40 0.6× 13 0.2× 37 526
Achille Bianchi Italy 6 354 0.6× 201 0.6× 40 0.2× 32 0.4× 18 0.3× 7 455
Ina Callebaut Belgium 15 124 0.2× 258 0.7× 84 0.4× 40 0.6× 29 0.4× 38 595
Elżbieta M. Grabczak Poland 12 299 0.5× 166 0.5× 63 0.3× 64 0.9× 91 1.3× 49 449
Chiara Scelfo Italy 12 147 0.2× 119 0.3× 37 0.2× 52 0.7× 26 0.4× 19 314
R. Nové-Josserand France 14 330 0.6× 70 0.2× 94 0.5× 113 1.6× 6 0.1× 34 602
Terry V. Grissell Australia 9 368 0.6× 441 1.2× 57 0.3× 233 3.2× 12 0.2× 10 720
Joanna Peradzyńska Poland 9 163 0.3× 103 0.3× 35 0.2× 88 1.2× 37 0.5× 20 283
E.H.J. van Haren Netherlands 7 553 0.9× 107 0.3× 39 0.2× 169 2.3× 11 0.2× 9 752
Prapaporn Pornsuriyasak Thailand 13 144 0.2× 102 0.3× 50 0.3× 61 0.8× 12 0.2× 32 320

Countries citing papers authored by Hans Slabbynck

Since Specialization
Citations

This map shows the geographic impact of Hans Slabbynck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Slabbynck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Slabbynck more than expected).

Fields of papers citing papers by Hans Slabbynck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Slabbynck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Slabbynck. The network helps show where Hans Slabbynck may publish in the future.

Co-authorship network of co-authors of Hans Slabbynck

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Slabbynck. A scholar is included among the top collaborators of Hans Slabbynck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Slabbynck. Hans Slabbynck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dorpe, Jo Van, Isabelle Peene, Karin Melsens, et al.. (2025). Endogenous Lipoid Pneumonia in Adult Autoinflammatory Disease. Arthritis Care & Research. 77(10). 1184–1193.
2.
Froidure, Antoine, Benjamin Bondue, Caroline Dahlqvist, et al.. (2023). Clinical course of suspected familial and sporadic idiopathic pulmonary fibrosis: Data from the PROOF‐Next registry. Respirology. 29(4). 304–311. 3 indexed citations
3.
Wuyts, Wim, Caroline Dahlqvist, Hans Slabbynck, et al.. (2022). Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry. Pulmonary Therapy. 8(2). 181–194. 7 indexed citations
4.
Wuyts, Wim, Caroline Dahlqvist, Hans Slabbynck, et al.. (2019). Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry. Respiratory Research. 20(1). 231–231. 18 indexed citations
6.
Vermeersch, Kristina, Ann Belmans, Kris Bogaerts, et al.. (2019). Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo – a post-hoc analysis of the BACE randomized controlled trial. Respiratory Research. 20(1). 237–237. 13 indexed citations
8.
Raskin, Jo, Hans Slabbynck, & Karolien Beel. (2016). Derrame linfomatoso primario bilateral, no asociado al herpesvirus humano 8, en un paciente con hipervolemia crónica. Archivos de Bronconeumología. 52(9). 492–493. 1 indexed citations
9.
Vermeersch, Kristina, Ingel Demedts, Hans Slabbynck, et al.. (2016). The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial. International Journal of COPD. 11. 687–687. 10 indexed citations
11.
Slabbynck, Hans, et al.. (2013). Use of an Amplatzer Device for Endoscopic Closure of a Large Bronchopleural Fistula following Lobectomy for a Stage I Squamous Cell Carcinoma. Case Reports in Oncology. 6(3). 550–554. 7 indexed citations
12.
Brusselle, Guy, Paul Jordens, R DEMAN, et al.. (2013). Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax. 68(4). 322–329. 328 indexed citations
13.
Slabbynck, Hans. (2011). La flor azul en el paisaje tecnológico: cine y experiencia en Walter Benjamín / Miriam Hansen.. PubMed Central. 34(3). 251–256. 4 indexed citations
14.
Schuerwegh, Annemie J., et al.. (2006). Wegener’s granulomatosis presenting as a thyroid mass. Clinical Rheumatology. 26(3). 454–456. 7 indexed citations
15.
Noppen, Marc, et al.. (2002). Manual Aspiration versus Chest Tube Drainage in First Episodes of Primary Spontaneous Pneumothorax: A Multicenter, Prospective, Randomized Pilot Study. American Journal of Respiratory and Critical Care Medicine. 165(9). 1240–1244. 178 indexed citations
16.
Slabbynck, Hans, et al.. (2000). Echocardiographic diagnosis of platypnoea-orthodeoxia syndrome after blunt chest trauma. Acta Cardiologica. 55(3). 199–201. 9 indexed citations
17.
Slabbynck, Hans, et al.. (1998). Unilateral Segmental Hyperhidrosis Associated With Pulmonary Adenocarcinoma. CHEST Journal. 114(4). 1215–1217. 8 indexed citations
18.
Mertens, An, et al.. (1996). Diagnostic value of direct examination of protected specimen brush samples in nosocomial pneumonia. European Journal of Clinical Microbiology & Infectious Diseases. 15(10). 807–810. 10 indexed citations
19.
Slabbynck, Hans, et al.. (1994). Spectacular Bone Scintigraphy and Transverse SPECT Images in Primary Osteosarcoma of the Pleura. Clinical Nuclear Medicine. 19(8). 738–739. 7 indexed citations
20.
Slabbynck, Hans, et al.. (1993). Dyspnea, Fever, and Eosinophilia. CHEST Journal. 104(2). 585–586. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026